Translational Development Acquisition Corp. | SPAC Research

Translational Development Acquisition Corp.

Status: Pre-Deal

U=S+W/2 W=S@11.50

IPO Proceeds, $M	$172.50M
IPO Date	Dec 23, 2024
CEO	Michael B. Hoffman
Left Lead	BTIG
IPO Cash in Trust	101.0%
SPAC Tenor	18 months
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	TBD
Deal Announced	TBD
Deal Size, $M	TBD
Deal Sector	TBD
Deal Geography	TBD
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	TBD

TDAC TDACU TDACW

Price	$10.15
Last closing price	$10.16
H/L, today	$10.15 / $10.15
H/L, 52-week	$10.58 / $16.87
Volume, today	100,000
Volume, 3-month avg.	N/A

Price	$10.25
Last closing price	$10.25
High/low price, today	$10.25 / $10.25
High/low price, 52-week	$11.85 / $25.69
Volume, today	371
Volume, 3-month avg.	N/A

Price	$0.16
Last closing price	$0.20
High/low price, today	$0.15 / $0.18
High/low price, 52-week	$0.22 / $4.18
Volume, today	42,521
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.